XML 29 R18.htm IDEA: XBRL DOCUMENT
v3.25.3

REDEEMABLE NONCONTROLLING INTERESTS IN EQUITY OF CONSOLIDATED SUBSIDIARIES | 9 Months Ended
--- | ---
Sep. 30, 2025
Noncontrolling Interest [Abstract] |
REDEEMABLE NONCONTROLLING INTERESTS IN EQUITY OF CONSOLIDATED SUBSIDIARIES | REDEEMABLE NONCONTROLLING INTERESTS IN EQUITY OF CONSOLIDATED SUBSIDIARIES Certain of our investees’ partnership and operating agreements contain terms that, upon the occurrence of specified events, could obligate us to purchase some or all of the noncontrolling interests related to our consolidated subsidiaries. The noncontrolling interests subject to these provisions, and the income available to those interests, are not included as part of our equity and are presented as redeemable noncontrolling interests in the accompanying Condensed Consolidated Balance Sheets at September 30, 2025 and December 31, 2024. The following table presents the changes in redeemable noncontrolling interests in equity of consolidated subsidiaries:
|  | Nine Months Ended September 30,
|  | 2025 |  | 2024
Balances at beginning of period |  | $ | 2,727 |  |  | $ | 2,391 |
Net income |  | 381 |  |  | 336 |
Distributions paid to noncontrolling interests |  | (311) |  |  | (269) |
Accretion of redeemable noncontrolling interests |  | — |  |  | 5 |
Purchases and sales of businesses and noncontrolling interests, net |  | 120 |  |  | 186 |
Balances at end of period |  | $ | 2,917 |  |  | $ | 2,649 |
The divestiture of the AL Hospitals during the three months ended September 30, 2024 resulted in a decrease of $175 million in our redeemable noncontrolling interest balance during the same period. The following tables present the composition by segment of our redeemable noncontrolling interests balances, as well as our net income available to redeemable noncontrolling interests:
|  | September 30, 2025 |  | December 31, 2024
Hospital Operations |  | $ | 879 |  |  | $ | 800 |
Ambulatory Care |  | 2,038 |  |  | 1,927 |
Redeemable noncontrolling interests |  | $ | 2,917 |  |  | $ | 2,727 |
|  | Nine Months Ended September 30,
|  | 2025 |  | 2024
Hospital Operations |  | $ | 82 |  |  | $ | 74 |
Ambulatory Care |  | 299 |  |  | 262 |
Net income available to redeemable noncontrolling interests |  | $ | 381 |  |  | $ | 336 |
In June 2022, we entered into a share purchase agreement to acquire the 5% ownership interest then-held by Baylor University Medical Center in USPI for $406 million. Under the share purchase agreement, we were obligated to make non‑interest-bearing monthly payments through June 2025. We repaid the outstanding balance under the share purchase agreement in full during the three months ended June 30, 2025. At December 31, 2024, the remaining obligation under the share purchase agreement of $68 million was included in other current liabilities in the accompanying Condensed Consolidated Balance Sheet.

X
- Definition The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 810 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/810/tableOfContent + Details
Name: | us-gaap_MinorityInterestDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_NoncontrollingInterestAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration